Management Team

Our management team offers a wealth of cardiovascular device testing experience, technical expertise and regulatory knowledge to our clients at all stages in the development of their cardiovascular devices.

Scott Phillips, CEO

scott-phillips-webres-6325Scott Phillips is CEO of the StarFish group of companies, including StarFish Medical and ViVitro Labs Inc. He holds a degree in Engineering Physics from the University of British Columbia. Under his leadership StarFish has grown into a diverse professional organization with clients around the world and 100% focus on medical devices. Scott is a Fellow of The Canadian Academy of Engineering, winner of the EY Entrepreneur Of The Year™ 2017 Pacific Awards Technology category, 2017 recipient of the VIATEC Technology Champion award, member of the LifeSciences British Columbia board, and volunteers with Junior Achievement, Entrepreneurs Organization, and University of British Columbia.

Rob Fraser MSc, Acting General Manager

Rob Fraser joined ViVitro Labs in 2012 as a Mechanical Engineer. Named Lab Manager in 2014, Rob is a Standards Council of Canada (SCC) Member to ISO/TC 150/SC 2 – Cardiovascular implants and extracorporeal systems (ISO 5840) committee. One of only two Canadian members on the committee, Rob holds a Masters in Biomedical/Mechanical Engineering from Queens University and a B.Sc. degree in Biomedical Mechanical Engineering from University of Alberta. “I joined the ISO/TC 150/SC 2 committee to better guide ViVitro clients with any hurdles, keep up with industry trends and make sure our clients’ needs and concerns were addressed in the evolving regulatory requirements”

Virginia Anastassova, Regulatory Affairs Manager/ Senior QA Specialist

Virginia Anastassova, RAC, B.Sc., acts as ViVitro’s QA Manager and is a regulatory affairs professional with more than 18 years of experience in the pharmaceutical and medical device industries, having acted as a regulatory affairs manager at Genzyme, Sorin Group and Vifor Pharma before joining StarFish Group. She has an extensive scientific background with a focus on cancer, HIV and iron deficiency anemia drug research and development. Virginia has played instrumental roles in the preparation and maintenance of corporate regulatory strategies, as well as NDA, MAA, IND, IDE, PMA and 510(k) regulatory submissions. Her GXP experience includes GCP, GLP, GMP and GDP. She is ISO 13485 Lead Auditor certified.


Sign up for our newsletter today